Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Cytogenetics

Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Customized Any 10 Markers Test

Immunophenotyping by Flow Cytometry is a specialized test used to identify and classify leukemia types by analyzing cell surface markers. Essential for accurate diagnosis and treatment planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL of whole blood in a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube, OR 2 mL of Bone Marrow in a Green Top tube along with an aspirate smear.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. However, please inform the laboratory of any relevant clinical history or medications.
Test priceKSh 26,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Customized Any 10 Markers Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspicion of leukemia based on clinical symptoms or blood counts.
  • ✓Diagnosis and classification of acute or chronic leukemia.
  • ✓Monitoring response to leukemia treatment.
  • ✓Identifying minimal residual disease (MRD).
  • ✓Evaluating patients with unexplained cytopenias.
  • ✓Characterizing lymphoproliferative disorders.
02

In plain language

What this test helps you understand

This test is essential for the diagnosis, classification, and monitoring of leukemia and other hematological malignancies. It helps determine the specific lineage and maturation stage of abnormal cells, guiding treatment decisions and assessing prognosis.
The Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel is a crucial diagnostic procedure used to identify and classify different types of leukemia. This advanced test employs flow cytometry technology to analyze blood or bone marrow samples, providing detailed information about the specific markers present on the surface of blood cells. This information is vital for accurate diagnosis and treatment planning. This specific panel allows for the customization of up to 10 markers based on clinical suspicion. Understanding the specific markers helps healthcare providers determine the exact type of leukemia and tailor the most effective treatment strategy.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. However, please inform the laboratory of any relevant clinical history or medications.
Sample3 mL of whole blood in a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube, OR 2 mL of Bone Marrow in a Green Top tube along with an aspirate smear.
MethodologyFlow Cytometry. This technique uses lasers and detectors to analyze the physical and chemical characteristics of cells as they flow in a stream past the laser beam. Antibodies tagged with fluorescent dyes bind to specific cell surface markers, allowing for their identification and quantification.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Test results must be interpreted in conjunction with clinical findings, patient history, and other laboratory tests. The accuracy depends on sample quality and handling. Certain rare leukemia subtypes may not be fully characterized by standard marker panels.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique that identifies specific proteins (markers) on the surface of cells using antibodies. In this test, it helps identify the type of leukemia cells.
This test is crucial for accurately diagnosing leukemia, determining its specific type, and guiding appropriate treatment decisions.
The test requires either a blood sample (collected in specific tubes) or a bone marrow sample.
Confirm with the laboratory before booking.
No fasting is required for this test.
Samples should be shipped immediately at 18°C to 22°C. Refrigeration or freezing must be avoided.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Catecholamines Plasma Test

Measures epinephrine and norepinephrine levels in plasma to help detect hormonal imbalances related to conditions like hypertension and anxiety. Confirm with the laboratory before booking.

Learn more →

Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test

Detects Epstein-Barr Virus (EBV) RNA in tumor tissue to aid in the early diagnosis of EBV-related cancers like lymphomas and nasopharyngeal carcinoma.

Learn more →

CA Cyfra 211 Lung Cancer Marker Test

The CA Cyfra 21-1 Lung Cancer Marker Test measures a specific protein fragment in the blood that can be elevated in lung cancer. It aids in diagnosis and monitoring.

Learn more →

Breast Cancer ER PR HER2 Ki67

The Breast Cancer ER PR HER2 Ki67 test analyzes key markers in breast tumor tissue to guide personalized treatment decisions. It measures hormone receptors (ER, PR), HER2 protein, and the Ki-67 proliferation marker.

Learn more →
Chat on WhatsApp